Quidel | QDEL - Sales Revenues


Quidel reported $620M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Agilent USD 1.8B 63M Dec/2025
Avanos Medical USD 182.2M 1.3M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Danaher USD 5.95B 890M Mar/2026
Haemonetics USD 346M 7.03M Mar/2026
Illumina USD 1.09B 70M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Merit Medical Systems USD 381.9M 12M Mar/2026
Mettler Toledo International USD 947.13M 182.87M Mar/2026
Myriad Genetics USD 200.4M 9.4M Mar/2026
Neogen USD 211.2M 13.49M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quidel USD 620M 104M Mar/2026
Revvity USD 711M 61.06M Mar/2026
STAAR Surgical USD 93.5M 145.9M Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Waters USD 1.27B 338M Mar/2026